Servier is a leading French pharmaceutical company that specializes in research, development, and manufacturing of innovative medicines. The company has a strong presence in the global market with operations in over 150 countries. Servier has a diverse portfolio of products that cater to various therapeutic areas, including cardiovascular disease, oncology, diabetes, and neurology.

As a responsible corporate citizen, Servier is committed to reducing its carbon footprint and promoting sustainable practices. The company has set ambitious targets to reduce its greenhouse gas emissions and achieve decarbonisation. Servier is working towards reducing its carbon emissions by 30% by 2025 and 50% by 2030. The company has also pledged to achieve carbon neutrality by 2050.

To achieve its decarbonisation goals, Servier is investing in renewable energy and energy-efficient technologies. The company has implemented several initiatives to reduce its energy consumption and promote the use of clean energy. Servier has installed solar panels on the roofs of its manufacturing facilities to generate clean energy. The company has also invested in wind farms and biomass plants to produce renewable energy.

Servier is also exploring corporate power purchase agreements (PPAs) to procure renewable energy. PPAs are long-term contracts between a company and a renewable energy provider, which guarantee a fixed price for the purchase of clean energy. Servier is working with renewable energy providers to explore the possibility of entering into PPAs to meet its energy needs.

In addition to promoting renewable energy, Servier is also focusing on reducing its energy consumption through energy-efficient technologies. The company has implemented several initiatives to optimize its energy use, including the installation of energy-efficient lighting and HVAC systems. Servier is also investing in energy-efficient equipment and processes to reduce its energy consumption.

Servier's commitment to decarbonisation and sustainable practices is reflected in its corporate energy strategy. The company has established a dedicated team to manage its energy consumption and promote sustainable practices. The team is responsible for identifying opportunities to reduce energy consumption, implementing energy-efficient technologies, and promoting renewable energy.

Servier's efforts to promote sustainability and reduce its carbon footprint have been recognized by various organizations. The company has been awarded several certifications, including ISO 14001 for environmental management and ISO 50001 for energy management. Servier has also been included in the CDP Climate A List, which recognizes companies for their efforts to combat climate change.

In conclusion, Servier is a leading French pharmaceutical company that is committed to promoting sustainability and reducing its carbon footprint. The company has set ambitious targets to achieve decarbonisation and is investing in renewable energy and energy-efficient technologies to meet its goals. Servier's corporate energy strategy is focused on reducing energy consumption, promoting renewable energy, and implementing sustainable practices. The company's efforts have been recognized by various organizations, and Servier is well-positioned to continue its leadership in promoting sustainability in the pharmaceutical industry.